Osaic Holdings
NRIX icon

Osaic Holdings’s Nurix Therapeutics NRIX Stock Holding History

Osaic Holdings’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.9K Sell
1,928
-76
-4% -$1.26K ﹤0.01% 5585
2025
Q4 		$38K Buy
2,004
+270
+16% +$3.88K ﹤0.01% 5427
2025
Q3 		$16K Sell
1,734
-8
-0.5% -$83 ﹤0.01% 6081
2025
Q2 		$19.8K Buy
1,742
+467
+37% +$5.05K ﹤0.01% 5715
2025
Q1 		$15.1K Buy
1,275
+462
+57% +$7.73K ﹤0.01% 5543
2024
Q4 		$15.3K Sell
813
-484
-37% -$11.1K ﹤0.01% 5519
2024
Q3 		$29.1K Buy
1,297
+14
+1% +$317 ﹤0.01% 5125
2024
Q2 		$26.8K Buy
+1,283
New +$20K ﹤0.01% 5139
2022
Q4 		– Sell
-1,000
Closed -$13K – 7357
2022
Q3 		$13K Buy
+1,000
New +$15.8K ﹤0.01% 5872

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Osaic Holdings's NRIX Position: Q1 2026 in Review

Osaic Holdings reduced its Nurix Therapeutics (NRIX) stake by 3.8% in Q1 2026, selling an estimated $1.26K and leaving 1,928 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5585.

Osaic Holdings first reported a position in NRIX in Q3 2022 and has held it in 9 quarters since. The position peaked at $38K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Osaic Holdings held 1,928 shares of Nurix Therapeutics worth $29.9K as of Q1 2026.
  • Osaic Holdings sold 76 Nurix Therapeutics shares in Q1 2026, an estimated $1.26K.
  • Nurix Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5585 holding.
  • Osaic Holdings first reported a position in Nurix Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • Osaic Holdings's Nurix Therapeutics position peaked at $38K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.